Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure

Recruiting Observational Study
Adverse Drug Reaction Therapy Failure
Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 and older
Sex
Any
Study type
Observational
Participants needed
400 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Genetic makeup of a patient influences the efficacy and safety profile of a drug. This study is to summarize individual cases, where Pharmacogenetics (PGx) has been applied during pharmaceutical care. The primary objective is the compilation of case reports, where pharmacogenetic testing is applied to determine the hereditable component of the patient's susceptibility to experience therapy failure…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * New medication with known PGx association (preemptive) * Current medication with observation of adverse drug reactions probably linked to drugs with known PGx association (reactive) * Current medication with observation of therapy failure probably linked to drugs with known PG…
Contacts

Samuel Allemann, Prof. Dr.

+41 61 207 61 76

s.allemann@unibas.ch

CONTACT

Kurt Hersberger, Prof. Dr.

+41 61 207 1971

kurt.hersberger@unibas.ch

CONTACT